Radioactive waste advisers training course

Course dates

29 September – 1 October 2025

Venue

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK.

Waste adviser wearing protective uniform surveying barrels of radioactive waste

Credit: AP Photo/Lee Jin-man

This course is organised by the Joint Department of Physics of The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

Course outline

This course provides the theoretical background and training necessary for the management of unsealed and sealed radioactive substances in hospitals.

The first day covers the following subject areas: interaction and units, instrumentation, radiation effects and risks and the regulatory framework. The following two days cover the legislation, applying for a Permit and compliance with the Permit conditions, the transport regulations and practical management of radioactive substances in hospitals. As well as lectures, there will be workshop sessions covering some practical issues. The course centres on UK (English) Legislation. 

The course is at a level suitable for hospital physicists working in the field of radiation protection or those who want to expand their knowledge in this field. It is particularly suitable for those wishing to become Radioactive Waste Advisers (RWA), and covers the Basic Underpinning Knowledge (Basic Syllabus) as set out in the RPA2000 Guidance.

This is a CPD course approved by IPEM.  

Those wishing to use the course towards RWA certification can sit an optional marked short exam.

Provisional Lecture List

Day 1: Review and effects of radiation

  • Interactions and units
  • Instrumentation
  • Sources of exposures
  • Risks and effects
  • Radiation protection framework
  • Other legislation

Day 2: Statutory requirements

  • EPR2016
  • Permit compliance / BAT
  • Transport Regulations
  • Applying for an environmental permit
  • IRAT2
  • Cradle to grave: records management

Day 3: Radioactive source management in hospitals

  • HASS and other sealed sources
  • Security
  • RWA certification
  • RWA Portfolio Assessment
  • Optional assessment

Workshops

  • EPR audits
  • Incidents

The organisers may need to alter the final programme to fulfil practical commitments.

Course fees

 Full three days including first day review: Two-day module excluding 1st day review (for those who have already attended RPTC in past 5 years) 
Payments received on or before 1 August 2025 £450£315
Payments received after 1 August 2025

 £525

£420

The cost includes lunches and light refreshments. Lecture notes and a certificate of attendance are provided.

Registration

Online Registration Form

Downloadable Registration Form

You will be allocated a place on receipt of a completed registration form and purchase order or completed online payment. We are unable to accept provisional bookings.

The number of participants is limited, so early booking is advised.  Applications from outside the UK are welcome.

Closing date for registrations: Friday 5 September 2025

Related documents

2 Day Course - Provisional Timetable 2025

3 Day Course - Provisional Timetable 2025

Sutton Site Map

Contacts

Course organiser: Dr Allison Craig 

For registration details and any other queries contact:

Course administrator: Mrs Jessica Keegan.

 

Latest ICR News

Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spread

30/07/25

A collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously unidentified fragments called shearosomes as tumour cells squeeze through narrow blood vessels. Shearosomes appear to actively influence their surroundings, supporting the growth of secondary tumours, offering new insights into how cancer spreads.
See full story
Turning cancer’s weakness into a weapon: 20 years of PARP inhibitors and BRCA research

29/07/25 - Robbie Lockyer

Two decades ago, a pivotal exchange between two scientists sparked a scientific and medical revolution. Professor Alan Ashworth, then Director of the Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, London, and his collaborator Professor Steve Jackson had long known that inherited genetic mutations in the genes BRCA1 and BRCA2 increase the risk of cancer. But, they wondered, what if those same mutations could be turned against the cancer itself?
See full story
Breast cancer cells (stained with anti-cytokeratin - green) invading through a layer of fibroblasts (stained for actin - red). Nuclei were counterstained with DAPI - blue
Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatment

18/07/25

Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting treatment.
See full story
A picture of a radiotherapy machine in a hospital
Targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

15/07/25

Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective at controlling the disease in the long term.
See full story